Atlas Trials

Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT01547104 · UNKNOWN

Trial details

NCT number
NCT01547104
Sponsor
Marcus Borchert
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus Type 2
Start date
2012-04-01
Primary completion
2012-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.